Symptom Severity and Treatment Satisfaction in Patients with Idiopathic Hypersomnia: The Real World Idiopathic Hypersomnia Outcomes Study (ARISE)

Autor: Schneider LD, Stevens J, Husain AM, Ito D, Fuller DS, Zee PC, Macfadden W

Publikováno v: Nature and Science of Sleep, Vol Volume 15, Pp 89-101 (2023)

Logan Douglas Schneider,1 Joanne Stevens,2 Aatif M Husain,3 Diane Ito,4 Douglas S Fuller,5 Phyllis C Zee,6 Wayne Macfadden2 1Stanford University Sleep Medicine Center, Stanford University School of Medicine, Stanford, CA, USA; 2Global Medical Affairs

Externí odkaz: https://doaj.org/article/f423cc4f071e4905b69c9183983af5d7

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Effectiveness and optimization of low-sodium oxybate in participants with narcolepsy switching from a high-sodium oxybate: data from the Substitution of Equal Grams of Uninterrupted Xyrem to Xywav study.

Autor: Macfadden W; Jazz Pharmaceuticals, Philadelphia, Pennsylvania., Leary EB; Jazz Pharmaceuticals, Palo Alto, California., Fuller DS; Jazz Pharmaceuticals, Philadelphia, Pennsylvania., Kirby MT; Jazz Pharmaceuticals, Philadelphia, Pennsylvania., Roy A; Ohio Sleep Medicine and Neuroscience Institute, Dublin, Ohio.

Publikováno v: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine [J Clin Sleep Med] 2024 Sep 01; Vol. 20 (9), pp. 1467-1477.

Dosing and transition characteristics in people with narcolepsy transitioning from sodium oxybate to low-sodium oxybate: Data from the real-world TENOR study.

Autor: Husain AM; Duke University Medical Center, Durham, NC, USA. Electronic address: aatif.husain@duke.edu., Zee PC; Northwestern University, Feinberg School of Medicine, Chicago, IL, USA., Leary EB; Jazz Pharmaceuticals, Palo Alto, CA, USA., Fuller DS; Jazz Pharmaceuticals, Philadelphia, PA, USA., Macfadden W; Jazz Pharmaceuticals, Philadelphia, PA, USA., Candler S; Jazz Pharmaceuticals, Philadelphia, PA, USA., Whalen M; Jazz Pharmaceuticals, Philadelphia, PA, USA., Bae CJ; Penn Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Publikováno v: Sleep medicine [Sleep Med] 2024 Jan; Vol. 113, pp. 328-337. Date of Electronic Publication: 2023 Nov 25.

Seizure-free days as a novel outcome in patients with Lennox-Gastaut syndrome: Post hoc analysis of patients receiving cannabidiol in two randomized controlled trials.

Autor: Auvin S; Assistance Publique - Hôpitaux de Paris (APHP), Service de Neurologie Pédiatrique, EpiCARE European Reference Network (ERN) membre, Hôpital Robert Debré, Paris, France.; Institut national de la santé et de la recherche médicale (INSERM) NeuroDiderot, Université Paris-Cité, Paris, France.; Institut Universitaire de France (IUF), Paris, France., Nortvedt C; Jazz Pharmaceuticals, Inc., London, UK., Fuller DS; Jazz Pharmaceuticals, Inc., Palo Alto, California, USA., Sahebkar F; Jazz Pharmaceuticals, Inc., Palo Alto, California, USA.

Publikováno v: Epilepsia [Epilepsia] 2023 Jul; Vol. 64 (7), pp. 1812-1820. Date of Electronic Publication: 2023 Apr 28.